|Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT)|
HY Meltzer, L Alphs, AI Green, AC Altamura, R Anand, A Bertoldi, ...
Archives of general psychiatry 60 (1), 82-91, 2003
|A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.|
G Chouinard, B Jones, G Remington, D Bloom, D Addington, ...
Journal of clinical psychopharmacology, 1993
|The extrapyramidal symptoms rating scale|
Can. J. Neurol. Sci. 7, 233-244, 1980
|The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.|
SR Marder, JM Davis, G Chouinard
The Journal of clinical psychiatry, 1997
|Placebo-controlled study of gabapentin treatment of panic disorder|
AC Pande, MH Pollack, J Crockatt, M Greiner, G Chouinard, RB Lydiard, ...
Journal of clinical psychopharmacology 20 (4), 467-471, 2000
|Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics|
G Chouinard, BD Jones
Am J Psychiatry 137 (1), 16-21, 1980
|Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder|
J Greist, G Chouinard, E DuBoff, A Halaris, SW Kim, L Koran, M Liebowitz, ...
Archives of General Psychiatry 52 (4), 289-295, 1995
|Manual for the extrapyramidal symptom rating scale (ESRS)|
G Chouinard, HC Margolese
Schizophrenia research 76 (2-3), 247-265, 2005
|Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.|
The journal of clinical psychiatry 65, 7-12, 2004
|Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.|
AM Ghadirian, G Chouinard, L Annable
Journal of Nervous and Mental Disease, 1982
|Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.|
FW Reimherr, G Chouinard, CK Cohn, JO Cole, TM Itil, YD LaPierre, ...
The Journal of clinical psychiatry, 1990
|Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study|
G Chouinard, L Annable, R Fontaine, L Solyom
Psychopharmacology 77 (3), 229-233, 1982
|Antimanic effect of clonazepam.|
G Chouinard, SN Young, L Annable
Biological psychiatry 18 (4), 451-466, 1983
|Neuroleptic-induced supersensitivity psychosis.|
G Chouinard, BD Jones, L Annable
The American journal of psychiatry, 1978
|Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial|
Y Dion, L Annable, P Sandor, G Chouinard
Journal of clinical psychopharmacology 22 (1), 31-39, 2002
|Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment|
R Fontaine, G Chouinard, L Annable
Am J Psychiatry 141 (7), 848-852, 1984
|Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder.|
G Chouinard, W Goodman, J Greist, M Jenike, S Rasmussen, K White, ...
Psychopharmacology Bulletin, 1990
|A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients|
HJ Möller, H Müller, RL Borison, NR Schooler, G Chouinard
European archives of psychiatry and clinical neuroscience 245 (1), 45-49, 1995
|A comparison of venlafaxine, trazodone, and placebo in major depression.|
LA Cunningham, RL Borison, JS Carman, G Chouinard, JE Crowder, ...
Journal of clinical psychopharmacology, 1994
|A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder|
A Halaris, SW Kimº, L Koranº, MR Liebowtiz, B Lydiardº, S McElroyº
International clinical psychopharmacology 10, 57-65, 1995